SCHEMBL30056525

SCHEMBL30056525

Cc1ccccc1-c1cc(=O)oc2cc(OC(C)C(=O)N3CCC[C@@H](C(=O)O)C3)ccc12

nearest known ligand 0.59

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ CYP3A4 P08684 1/20 0.59
▸ CYP2C9 P11712 1/20 0.59
▸ CYP2C19 P33261 1/20 0.59
▸ RAB9A P51151 1/20 0.56
▸ ALDH1A1 P00352 7/20 0.52
▸ KDM4E B2RXH2 7/20 0.52
▸ HPGD P15428 6/20 0.52
▸ KMT2A Q03164 4/20 0.49
▸ HSD17B10 Q99714 2/20 0.49
▸ MEN1 O00255 1/20 0.49
▸ USP2 O75604 1/20 0.49
▸ TSHR P16473 1/20 0.49
▸ HTT P42858 2/20 0.48
▸ MAPT P10636 1/20 0.48
▸ L3MBTL1 Q9Y468 1/20 0.48
▸ AR P10275 1/20 0.46
▸ RECQL P46063 1/20 0.44
▸ ALDH2 P05091 1/20 0.42
▸ IGLV6-57 P01721 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20839347 1.00 CYP3A4 (0.59) CYP3A4CYP2C9CYP2C19RAB9AALDH1A1
SCHEMBL20839458 1.00 CYP3A4 (0.59) CYP3A4CYP2C9CYP2C19RAB9AALDH1A1
SCHEMBL30058118 1.00 CYP3A4 (0.59) CYP3A4CYP2C9CYP2C19RAB9AALDH1A1
SCHEMBL30056586 1.00 CYP3A4 (0.59) CYP3A4CYP2C9CYP2C19RAB9AALDH1A1
SCHEMBL20839095 1.00 CYP3A4 (0.59) CYP3A4CYP2C9CYP2C19RAB9AALDH1A1
SCHEMBL20839096 1.00 CYP3A4 (0.59) CYP3A4CYP2C9CYP2C19RAB9AALDH1A1
SCHEMBL30762873 0.95 CYP3A4 (0.61) CYP3A4CYP2C9CYP2C19RAB9AALDH1A1
SCHEMBL20840631 0.95 CYP3A4 (0.61) CYP3A4CYP2C9CYP2C19RAB9AALDH1A1
SCHEMBL20839469 0.92 CYP3A4 (0.57) CYP3A4CYP2C9CYP2C19RAB9AALDH1A1
SCHEMBL30055797 0.92 CYP3A4 (0.57) CYP3A4CYP2C9CYP2C19RAB9AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111386261-B Coumarin derivatives, process for their preparation and their use in the treatment of cancer 利德发现中心有限责任公司 2024-03-22 — — CN claimed
EP-4333822-A1 COMPOSITION COMPRISING AN INHIBITOR OF MITOCHONDRIAL TRANSCRIPTION Lead Discovery Center GmbH (DE) 2024-03-13 — — EP claimed
WO-2022233782-A1 COMPOSITION COMPRISING AN INHIBITOR OF MITOCHONDRIAL TRANSCRIPTION LEAD DISCOVERY CENTER GMBH (DE) 2022-11-10 — — WO claimed
CN-111386261-B Coumarin derivatives, process for their preparation and their use in the treatment of cancer 利德发现中心有限责任公司 2024-03-22 — — CN disclosed
Send feedback